Sermorelin Dosage and Cycle

Dec 24, 2024 Leave a message

Sermorelin has been administered at a relatively wide range of doses in various human clinical trials via both intravenous (IV) and subcutaneous (sc) injection

As we have noted, sermorelin's mechanism of action leverages the natural GH secretion pathway with resulting GH levels maintained within a physiological range by the natural regulatory machinery .

As a result, the peptide is unique in that increasing sermorelin dosages above a certain level does not result in increased effects on GH and IGF-1. Nonetheless, we recommend that researchers use a conservative dosing protocol and use the minimal therapeutic dose.

A hypothetical dosing protocol to help researchers understand how sermorelin might be dosed in a potential trial is as follows:

• Tolerance assessment: To assess tolerance, begin with a dose of 100mcg injected subcutaneously. (Note that 1mg is equal to 1000mcg, and 100mcg is equal to 1/10th of a milligram)

• Low-dose protocol (200mcg/day): Since sermorelin has a short half-life, administer 100mcg via sc injection in the morning and again in the evening before bed, for a total of 200mcg.

• High-dose protocol (600mcg/day): For users who do not respond to the low dose protocol, administer 200mcg of sermorelin in the morning, afternoon, and prior to bedtime for a total of 600mcg.

The most useful biomarker for understanding whether sermorelin is having an effect at a given dosage is IGF-1. Therefore, to best assess the effects of a particular dose of sermorelin, we recommend that researchers get baseline blood work with follow-up bloodwork after at least 2 weeks at a given dosing protocol.

Based on the available literature, sermorelin does not appear to require cycling and has been administered in trials for up to 36 months of continuous usage.

Note that sermorelin peptide will be lyophilized into a freeze-dried powder after manufacturing to improve temperature stability and increase shelf life. Prior to injection, researchers will need to use bacteriostatic water to reconstitute and dissolve the freeze-dried peptide into an injectable liquid solution.

 

product-623-526

 

Send Inquiry

whatsapp

Phone

E-mail

Inquiry